PE
IDYA icon

Point72 Europe’s IDEAYA Biosciences IDYA Stock Holding History

Point72 Europe’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$89.1K Buy
+3,276
New +$79.2K ﹤0.01% 293

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Europe's IDYA Position: Q3 2025 in Review

Point72 Europe opened a new position in IDEAYA Biosciences (IDYA) in Q3 2025: 3,276 shares worth $89.1K. The stake represents ﹤0.01% of the portfolio and ranks #293 among its holdings.

224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • Point72 Europe held 3,276 shares of IDEAYA Biosciences worth $89.1K as of Q3 2025.
  • IDEAYA Biosciences was a new Point72 Europe position in Q3 2025.
  • IDEAYA Biosciences made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #293 holding.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.